|
인쇄하기
취소
|
Roche Korea under penalty on charge of poor manufacturing record-keeping.
Published: 2005-05-17 06:57:00
Updated: 2005-05-17 06:57:00
It is very likely that Roche Korea get penalized on charge of their negligence in keeping the drug manufacturing control records.
The Gyeongin KFDA (GKFDA) recently replied with the above possibility to the inquiry raised by the Korea Pharmaceutical Association about the inspection results over the broken incidences of Roche Madopar tablets.
The GKFDA said that the inspection on manufact...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.